Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07760896
The GLOW Study: GLP-1 and Lifestyle for Optimal WellnessSaundra JainNot Yet RecruitingNot Applicable
NCT07760896Not Yet Recruiting
Not Applicable
The GLOW Study: GLP-1 and Lifestyle for Optimal WellnessSaundra Jain
NCT07759557
Efficacy of A Non-Invasive Botulinum Toxin Microneedle Pad for the Treatment of Secondary Raynaud's PhenomenonKhon Kaen UniversityNot Yet RecruitingPhase 3
NCT07759557Not Yet Recruiting
Phase 3
Efficacy of A Non-Invasive Botulinum Toxin Microneedle Pad for the Treatment of...Khon Kaen University
NCT07759128
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety DisorderOtsuka Pharmaceutical Development & Commercialization, Inc.RecruitingPhase 3
NCT07759128Recruiting
Phase 3
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With G...Otsuka Pharmaceutical Dev...
NCT07761923
Preserving Muscle Mass During Incretin-Induced Weight LossKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07761923Not Yet Recruiting
Not Applicable
Preserving Muscle Mass During Incretin-Induced Weight LossKarolinska Institutet
NCT07761416
Opportunistic Salpingectomy During Bariatric Surgery for Ovarian Cancer PreventionSt. Joseph's Healthcare HamiltonNot Yet RecruitingEarly Phase 1
NCT07761416Not Yet Recruiting
Early Phase 1
Opportunistic Salpingectomy During Bariatric Surgery for Ovarian Cancer Preventi...St. Joseph's Healthcare H...
NCT07761286
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular CarcinomaCSPC Megalith Biopharmaceutical Co.,Ltd.Not Yet RecruitingPhase 1
NCT07761286Not Yet Recruiting
Phase 1
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection f...CSPC Megalith Biopharmace...
NCT07761065
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion in Skeletal Open Bite CasesAin Shams UniversityCompletedNot Applicable
NCT07761065Completed
Not Applicable
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion...Ain Shams University
NCT07759414
Chrono-Fasting in Overweight and Obese AdolescentsUniversity of ThessalyNot Yet RecruitingNot Applicable
NCT07759414Not Yet Recruiting
Not Applicable
Chrono-Fasting in Overweight and Obese AdolescentsUniversity of Thessaly
NCT07761702
Umbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-Risk AMLShanghai Jiao Tong University School of MedicineNot Yet RecruitingPhase 3
NCT07761702Not Yet Recruiting
Phase 3
Umbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-...Shanghai Jiao Tong Univer...
NCT07761598
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs instituteNot Yet RecruitingNot Applicable
NCT07761598Not Yet Recruiting
Not Applicable
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs institute
NCT07759180
Sterile Plant-Based Gauze for Eyelid Hygiene in Anterior BlepharitisAzienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'AragonaCompletedNot Applicable
NCT07759180Completed
Not Applicable
Sterile Plant-Based Gauze for Eyelid Hygiene in Anterior BlepharitisAzienda Ospedaliera OO.RR...
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07759895
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in SchizophreniaAmit LotanNot Yet RecruitingPhase 2
NCT07759895Not Yet Recruiting
Phase 2
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Sy...Amit Lotan
NCT07761429
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)Shandong New Time Pharmaceutical Co., LTDRecruitingPhase 2
NCT07761429Recruiting
Phase 2
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Tr...Shandong New Time Pharmac...
NCT07759284
Endotracheal Tube Intolerance and Respiratory Airflow PerceptionPeking University People's HospitalNot Yet Recruiting
NCT07759284Not Yet Recruiting
—
Endotracheal Tube Intolerance and Respiratory Airflow PerceptionPeking University People'...
NCT07760974
Evaluation the Accuracy of Immediate Implant Placement Using SocketFit Static Surgical Guide Versus Conventional Static Surgical Guide in Anterior Esthetic ZoneTanta UniversityRecruitingNot Applicable
NCT07760974Recruiting
Not Applicable
Evaluation the Accuracy of Immediate Implant Placement Using SocketFit Static Su...Tanta University
NCT07760636
Kinetics and Prognostic Value of NeuroFilament Light in Post-cardiac Arrest: A Prospective Multicenter StudyAssistance Publique - Hôpitaux de ParisNot Yet Recruiting
NCT07760636Not Yet Recruiting
—
Kinetics and Prognostic Value of NeuroFilament Light in Post-cardiac Arrest: A P...Assistance Publique - Hôp...
NCT07760948
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideAmerican Diabetes AssociationNot Yet RecruitingPhase 2
NCT07760948Not Yet Recruiting
Phase 2
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideAmerican Diabetes Associa...
NCT07761520
Prevention of Ischemia in Aneurysmal Subarachnoid Hemorrhage Through Remote Ischemic PreconditioningCentre Hospitalier Universitaire de NiceNot Yet RecruitingNot Applicable
NCT07761520Not Yet Recruiting
Not Applicable
Prevention of Ischemia in Aneurysmal Subarachnoid Hemorrhage Through Remote Isch...Centre Hospitalier Univer...
NCT07759102
Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple MyelomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07759102Not Yet Recruiting
Phase 1
Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refract...National Cancer Institute...
Result Breakdown
Not yet recruiting15 (75%)
Recruiting3 (15%)
Completed2 (10%)
not_applicable9 (45%)
Phase 33 (15%)
Phase 23 (15%)
Phase 12 (10%)
Not Specified2 (10%)
Early Phase 11 (5%)